A Lisbon private investor had the winning bid for the farm, which at one time was a major supplier of greens to Hannaford and ...

Comprehensive guide to starting MEK inhibitor therapy for NF1, covering preparation, dosing, pharmacy logistics, side effects, and management tips for patients.

Neurofibromatosis type 1 (NF1) specialists offered advice on using MEK1/2 inhibitors to manage plexiform neurofibromas in ...

The German pharmaceutical company Merck KGaA is negotiating the acquisition of the American manufacturer of drugs for the treatment of cancer and rare diseases SpringWorks Therapeutics Inc. This is ...

Germany’s Merck KGaA has agreed to acquire British biotechnology company Silence Therapeutics for approximately $1.3 billion in cash, accelerating its ...

Law360’s Practice Groups of the Year highlights up to five practice groups that notched the biggest litigation victories or deals of the year. Winners are recognized for the size, complexity and ...

Executive SummaryHow to Interpret Two Premiums and Explain the Acquisition Price of a Loss-Making Company (Merck's Acquisition of Silence Therapeutics)Why was a company with only about $560,000 in ...

Inquiries came from greenhouse users throughout the U.S and as far afield as the United Kingdom, Lebanon and Israel, the ...

Merck KGaA (-0.83%, at EUR143.10) announced that it has signed a definitive agreement to acquire British biotechnology company Silence Therapeutics, which specializes in developing therapies based on ...

Belén Garijo took over French drugmaker Sanofi with one overriding task: to secure a new blockbuster to succeed ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its entry into a definitive agreement to acquire Silence Therapeutics plc (Nasdaq: SLN), a global ...

B cell subsets contribute to long-term tumor control and improved overall patient survival in multiple tumor types.